Oduntan, S. A.; Gool, R. Y. (1970). «Clinical trial of ketamine (ci-581): A preliminary report». Canadian Anaesthetists' Society Journal17 (4): 411-6. PMID5429682. doi:10.1007/BF03004705.
Mason, Oliver J.; Morgan, Celia J.M.; Stefanovic, Ana; Curran, H Valerie (2008). «The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis». Schizophrenia Research103 (1–3): 138-42. PMID18387788. doi:10.1016/j.schres.2008.02.020.
Gouzoulis-Mayfrank, E.; Heekeren, K.; Neukirch, A.; Stoll, M.; Stock, C.; Obradovic, M.; Kovar, K.-A. (2005). «Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers». Pharmacopsychiatry38 (6): 301-11. PMID16342002. doi:10.1055/s-2005-916185.
Vollenweider, F; Geyer, MA (2001). «A systems model of altered consciousness: integrating natural and drug-induced psychoses». Brain Research Bulletin56 (5): 495-507. PMID11750795. doi:10.1016/S0361-9230(01)00646-3.
Adams HA (December 1997). «[S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia-sedation]» [S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia-sedation]. Der Anaesthesist(en alemán)46 (12): 1081-7. PMID9451493. doi:10.1007/s001010050510.
Barrett W, Buxhoeveden M, Dhillon S (October 2020). «Ketamine: a versatile tool for anesthesia and analgesia». Current Opinion in Anesthesiology33 (5): 633-638. PMID32826629. doi:10.1097/ACO.0000000000000916.
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB (April 2017). «A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders». JAMA Psychiatry74 (4): 399-405. PMID28249076. doi:10.1001/jamapsychiatry.2017.0080.
Marcantoni WS, Akoumba BS, Wassef M, Mayrand J, Lai H, Richard-Devantoy S, Beauchamp S (December 2020). «A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019». J Affect Disord277: 831-841. PMID33065824. doi:10.1016/j.jad.2020.09.007.
Oduntan, S. A.; Gool, R. Y. (1970). «Clinical trial of ketamine (ci-581): A preliminary report». Canadian Anaesthetists' Society Journal17 (4): 411-6. PMID5429682. doi:10.1007/BF03004705.
Mason, Oliver J.; Morgan, Celia J.M.; Stefanovic, Ana; Curran, H Valerie (2008). «The Psychotomimetic States Inventory (PSI): Measuring psychotic-type experiences from ketamine and cannabis». Schizophrenia Research103 (1–3): 138-42. PMID18387788. doi:10.1016/j.schres.2008.02.020.
Gouzoulis-Mayfrank, E.; Heekeren, K.; Neukirch, A.; Stoll, M.; Stock, C.; Obradovic, M.; Kovar, K.-A. (2005). «Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers». Pharmacopsychiatry38 (6): 301-11. PMID16342002. doi:10.1055/s-2005-916185.
Vollenweider, F; Geyer, MA (2001). «A systems model of altered consciousness: integrating natural and drug-induced psychoses». Brain Research Bulletin56 (5): 495-507. PMID11750795. doi:10.1016/S0361-9230(01)00646-3.
Adams HA (December 1997). «[S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia-sedation]» [S-(+)-ketamine. Circulatory interactions during total intravenous anesthesia and analgesia-sedation]. Der Anaesthesist(en alemán)46 (12): 1081-7. PMID9451493. doi:10.1007/s001010050510.
Barrett W, Buxhoeveden M, Dhillon S (October 2020). «Ketamine: a versatile tool for anesthesia and analgesia». Current Opinion in Anesthesiology33 (5): 633-638. PMID32826629. doi:10.1097/ACO.0000000000000916.
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB (April 2017). «A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders». JAMA Psychiatry74 (4): 399-405. PMID28249076. doi:10.1001/jamapsychiatry.2017.0080.
Marcantoni WS, Akoumba BS, Wassef M, Mayrand J, Lai H, Richard-Devantoy S, Beauchamp S (December 2020). «A systematic review and meta-analysis of the efficacy of intravenous ketamine infusion for treatment resistant depression: January 2009 - January 2019». J Affect Disord277: 831-841. PMID33065824. doi:10.1016/j.jad.2020.09.007.